{"id":4695,"date":"2025-06-18T23:02:52","date_gmt":"2025-06-18T23:02:52","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/06\/18\/bio-2025-conference-universities-private-equity-drug-development-obesity-most-favored-nation\/"},"modified":"2025-06-18T23:02:52","modified_gmt":"2025-06-18T23:02:52","slug":"bio-2025-conference-universities-private-equity-drug-development-obesity-most-favored-nation","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/06\/18\/bio-2025-conference-universities-private-equity-drug-development-obesity-most-favored-nation\/","title":{"rendered":"STAT+: More universities open to private equity deals, and emerging companies turn to new targets"},"content":{"rendered":"

STAT+: More universities open to private equity deals, and emerging companies turn to new targets
\n \t

\n
<\/BR>
\n
\n \t

\n
<\/BR><\/p>\n

\n

This is the online version of our BIO 2025 newsletter. Get more BIO updates directly to your inbox by signing up here<\/a>, and sign up for our morning biotech news roundup newsletter here<\/a>.<\/em><\/p>\n

Hello all,<\/p>\n

I have a fresh double shot of espresso in hand, which I\u2019m sure would please my colleague\u00a0Ed Silverman<\/a>, aka Pharmalot. BIO has been busy this year. From what I\u2019m hearing on the ground, attendance is quite good, with executives and industry reps flocking to the conference for guidance on federal policy, AI, and global competition.\u00a0<\/p>\n

Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n

\t

\n
<\/BR>
\n Allison DeAngelis and Elizabeth Cooney
\n \t

\n
<\/BR>
\nGo to statnews<\/a>
\n \t

\n
<\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"

STAT+: More universities open to private equity deals, and emerging companies turn to new targets This is the online version of our BIO 2025 newsletter. Get more BIO updates directly to your inbox by signing up here, and sign up for our morning biotech news roundup newsletter here. Hello all, I have a fresh double […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2971,2194,2154,2209,2282,2176,2152,2648],"tags":[2150],"class_list":["post-4695","post","type-post","status-publish","format-standard","hentry","category-bio","category-biotech","category-biotechnology","category-drug-prices","category-obesity","category-pharma","category-stat","category-weight-loss","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/4695"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=4695"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/4695\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=4695"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=4695"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=4695"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}